Moximed, an innovative medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that Michael Mydra has joined the company as Senior ...
Lifestyle changes become critical components of arthritis management. An appropriate diet, low-impact exercise, and ...
He added, “In advanced end-stage arthritis, not responding to mentioned measures, Joint Replacement is a very good option. It is now possible to change only part of the joint such as partial or half ...
“When we’re young, we’re constantly rebuilding the cartilage – the smooth, shiny stuff on the end of bones ... are about 100,000 hip and knee replacements performed in England each year and they are ...
Cynata Therapeutics (ASX:CYP) is the only clinical-stage ... to the pointy end with four trials underway, with three of them ...
AusBiotech has always been for its members. Built by our members, to be the national voice of our sector we are proud to support our member's growth ...
The global regenerative medicine market is projected to be valued at USD 35.82 billion in 2024 and is anticipated to grow to approximately USD 154.05 billion by 2033, with a CAGR of 18% during the ...
AusBiotech has always been for its members. Built by our members, to be the national voice of our sector we are proud to support our member's growth ...